Monday, March 4, 2013

• Threshold Pharmaceuticals: A Biotech Trading At Half Its Intrinsic Valueat Seeking Alpha (Mon, Mar 4)

Friday, March 1, 2013

• 5 Stocks Poised for Breakoutsat TheStreet (Fri, Mar 1)

Tuesday, February 26, 2013

• Threshold Pharmaceuticals Announces Presentation and Webcast at Cowen and Company's 33rd Annual Health Care ConferenceMarketwired (Tue, Feb 26)

Friday, February 22, 2013

• Biotech Investors: Please Don't Make This Mistakeat Motley Fool (Fri, Feb 22)

Thursday, February 21, 2013

• A Biotech Winner For 2013at Seeking Alpha (Thu, Feb 21)
• Whoa! These 3 Stocks Outmaneuvered the Dowat Motley Fool (Thu, Feb 21)
• 4 Biotech Stocks Under $10 Moving Higherat TheStreet (Thu, Feb 21)

Wednesday, February 20, 2013

• Three Noteworthy Analyst Calls on Wednesdayat Motley Fool (Wed, Feb 20)
• Movers roundup: Millennial Media, NetSpendAP (Wed, Feb 20)
• Movers roundup: Millenial Media, NetSpendAP (Wed, Feb 20)
• Threshold Pharma shares rise on analyst upgradeAP (Wed, Feb 20)
• Threshold Pharmaceuticals upgraded to Overweight from Neutral at Piper Jaffrayat theflyonthewall.com (Wed, Feb 20)

Tuesday, February 12, 2013

• 3 Biotech Stocks Under $10 Moving Higherat TheStreet (Tue, Feb 12)
• 3 Biotech Stocks Under $10 Making Big Movesat TheStreet (Tue, Feb 12)
• Will Celgene's $2.9 Billion Bet Pay Off?at Motley Fool (Tue, Feb 12)

Thursday, February 7, 2013

• Number of FDA Drug Approvals Reach a 15-Year High in 2012Marketwired (Thu, Feb 7)

Monday, February 4, 2013

• 2 Biotech Stocks With Upcoming Catalystsat Seeking Alpha (Mon, Feb 4)

Sunday, February 3, 2013

• 3 Biotechs Burning Through Cashat Motley Fool (Sun, Feb 3)

Tuesday, January 29, 2013

• Threshold/Merck KGaA Drug in StudyZacks (Tue, Jan 29)

Sunday, January 27, 2013

• Will Threshold's MAESTRO Hit the Right Note?at Motley Fool (Sun, Jan 27)
• Why Celgene Still Looks Cheapat Motley Fool (Sun, Jan 27)

Friday, January 25, 2013

• Stocks Continue to Climb as Companies Exceed Expectationsat TheStreet (Fri, Jan 25)
• A Look at Three Biotech Moversat Motley Fool (Fri, Jan 25)
• THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Other EventsEDGAR Online (Fri, Jan 25)
• Threshold takes pancreatic cancer drug into late-stage trial, nabs $30M paymentat bizjournals.com (Fri, Jan 25)

Add THLD News to My Yahoo!